Symbols / DCGO Stock $0.72 +4.55% DocGo Inc.

Healthcare • Medical Care Facilities • United States • NCM
DCGO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Lee Bienstock
Exch · Country NCM · United States
Market Cap 71.03M
Enterprise Value 31.03M
Income -182.40M
Sales 322.20M
FCF (ttm) 56.60M
Book/sh 1.46
Cash/sh 0.52
Employees 2,537
Insider 10d —
IPO Dec 17, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 4.11
PEG —
P/S 0.22
P/B 0.49
P/C —
EV/EBITDA -0.42
EV/Sales 0.10
Quick Ratio 2.13
Current Ratio 2.26
Debt/Eq 23.18
LT Debt/Eq —
EPS (ttm) -1.84
EPS next Y 0.17
EPS Growth —
Revenue Growth -38.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-03-16
ROA -16.57%
ROE -89.05%
ROIC —
Gross Margin 30.65%
Oper. Margin -43.29%
Profit Margin -56.61%
Shs Outstand 98.78M
Shs Float 96.10M
Insider Own 3.08%
Instit Own 42.65%
Short Float 6.65%
Short Ratio 4.19
Short Interest 6.40M
52W High 2.45
vs 52W High -70.65%
52W Low 0.49
vs 52W Low 46.46%
Beta 0.98
Impl. Vol. 25.00%
Rel Volume 0.40
Avg Volume 1.06M
Volume 427.61K
Target (mean) $2.10
Tgt Median $2.50
Tgt Low $1.00
Tgt High $3.00
# Analysts 5
Recom None
Prev Close $0.69
Price $0.72
Change 4.55%
About

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.10
Mean price target
2. Current target
$0.72
Latest analyst target
3. DCF / Fair value
$10.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.72
Low
$1.00
High
$3.00
Mean
$2.10

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-25 main Canaccord Genuity Hold → Hold $1
2026-03-17 main Stifel Buy → Buy $3
2026-03-17 reit Cantor Fitzgerald Overweight → Overweight $3
2026-03-17 reit Needham Buy → Buy $3
2025-11-12 main Canaccord Genuity Hold → Hold $2
2025-08-21 main Canaccord Genuity Hold → Hold $2
2025-05-12 down Canaccord Genuity Buy → Hold $1
2025-05-09 main Needham Buy → Buy $3
2025-04-08 reit Needham Buy → Buy $4
2025-02-28 main Stifel Buy → Buy $6
2025-02-28 main Needham Buy → Buy $4
2025-01-16 reit Needham Buy → Buy $7
2024-09-20 reit Cantor Fitzgerald Overweight → Overweight $5
2024-08-20 reit Cantor Fitzgerald Overweight → Overweight $5
2024-08-08 reit Needham Buy → Buy $7
2024-05-09 main BTIG Buy → Buy $7
2024-05-09 main Canaccord Genuity Buy → Buy $5
2024-05-09 main Needham Buy → Buy $7
2024-05-09 main Cantor Fitzgerald Overweight → Overweight $5
2024-04-30 main Stifel Buy → Buy $7
News
RSS: Latest DCGO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-15 TENDLER ELY D General Counsel — 16,850 $0.91 $15,334
2025-12-12 TRAVERS JAMES M Director — 150,000 $0.00 $0
2025-12-12 BURDIEK MICHAEL J Director — 150,000 $0.00 $0
2025-12-12 TENDLER ELY D General Counsel — 100,000 $0.00 $0
2025-12-12 ROSENBERG NORMAN Chief Financial Officer — 429,405 $0.00 $0
2025-12-12 LEITE ETALVINA Director — 150,000 $0.00 $0
2025-12-12 SMEDRA IRA Director — 150,000 $0.00 $0
2025-12-12 SUGRUE STEPHEN Officer — 321,055 $0.00 $0
2025-12-12 BIENSTOCK LEE Chief Executive Officer — 1,113,495 $0.00 $0
2025-09-10 KLASKO STEPHEN K Director — 100,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
322.20
-47.74%
616.56
-1.24%
624.29
+41.72%
440.52
Operating Revenue
322.20
-47.74%
616.56
-1.24%
624.29
+41.72%
440.52
Cost Of Revenue
223.44
-44.55%
402.98
-6.04%
428.91
+50.08%
285.79
Reconciled Cost Of Revenue
223.44
-44.55%
402.98
-6.04%
428.91
+50.08%
285.79
Gross Profit
98.76
-53.76%
213.57
+9.31%
195.38
+26.28%
154.72
Operating Expense
187.91
+1.64%
184.89
+2.53%
180.33
+35.70%
132.89
Research And Development
13.56
+17.03%
11.59
+6.73%
10.86
+101.65%
5.38
Selling General And Administration
158.69
+0.81%
157.41
+2.86%
153.04
+30.87%
116.94
Selling And Marketing Expense
1.42
-5.68%
1.51
-46.25%
2.80
-41.08%
4.76
General And Administrative Expense
157.27
+0.87%
155.91
+3.77%
150.24
+33.92%
112.18
Other Gand A
157.27
+0.87%
155.91
+3.77%
150.24
+33.92%
112.18
Total Expenses
411.35
-30.03%
587.87
-3.51%
609.23
+45.51%
418.68
Operating Income
-89.16
-410.77%
28.69
+90.56%
15.05
-31.04%
21.83
Total Operating Income As Reported
-178.03
-720.57%
28.69
+90.56%
15.05
-31.04%
21.83
EBITDA
-73.50
-264.89%
44.57
+41.56%
31.49
-2.81%
32.40
Normalized EBITDA
22.48
-48.29%
43.46
+40.65%
30.90
-5.27%
32.62
Reconciled Depreciation
15.66
-1.40%
15.88
-3.33%
16.43
+55.52%
10.57
EBIT
-89.16
-410.77%
28.69
+90.56%
15.05
-31.04%
21.83
Total Unusual Items
-95.97
-8752.19%
1.11
+89.62%
0.58
+363.35%
-0.22
Total Unusual Items Excluding Goodwill
-95.97
-8752.19%
1.11
+89.62%
0.58
+363.35%
-0.22
Special Income Charges
-95.97
-8752.19%
1.11
+89.62%
0.58
+143.35%
-1.35
Other Special Charges
—
—
1.00
—
Impairment Of Capital Assets
88.88
+969.95%
8.31
0.00
-100.00%
2.92
Restructuring And Mergern Acquisition
2.06
+121.89%
-9.39
-553.35%
-1.44
+9.79%
-1.59
Write Off
5.00
0.00
0.00
—
Net Income
-182.40
-1012.36%
19.99
+191.50%
6.86
-80.17%
34.58
Pretax Income
-187.50
-775.70%
27.75
+70.31%
16.29
-28.48%
22.78
Net Non Operating Interest Income Expense
-1.24
+35.61%
-1.93
-214.53%
1.68
+120.85%
0.76
Interest Expense Non Operating
—
1.93
—
—
Net Interest Income
-1.24
+35.61%
-1.93
-214.53%
1.68
+120.85%
0.76
Interest Expense
—
1.93
—
—
Interest Income Non Operating
—
—
1.68
+120.85%
0.76
Interest Income
—
—
1.68
+120.85%
0.76
Other Income Expense
-97.10
-9913.17%
0.99
+321.81%
-0.45
-337.81%
0.19
Other Non Operating Income Expenses
-0.57
-392.81%
0.20
+128.54%
-0.69
-271.59%
0.40
Gain On Sale Of Security
—
—
—
1.13
Tax Provision
8.87
-38.37%
14.39
+130.40%
6.24
+178.44%
-7.96
Tax Rate For Calcs
0.00
+0.00%
0.00
-45.21%
0.00
+82.52%
0.00
Tax Effect Of Unusual Items
-20.15
-8752.19%
0.23
+3.89%
0.22
+580.66%
-0.05
Net Income Including Noncontrolling Interests
-196.37
-1569.75%
13.36
+32.96%
10.05
-67.32%
30.74
Net Income From Continuing Operation Net Minority Interest
-182.40
-1012.36%
19.99
+191.50%
6.86
-80.17%
34.58
Net Income From Continuing And Discontinued Operation
-182.40
-1012.36%
19.99
+191.50%
6.86
-80.17%
34.58
Net Income Continuous Operations
-196.37
-1569.75%
13.36
+32.96%
10.05
-67.32%
30.74
Minority Interests
13.97
+110.62%
6.63
+307.89%
-3.19
-183.04%
3.84
Normalized Income
-106.58
-657.56%
19.12
+194.19%
6.50
-81.31%
34.76
Net Income Common Stockholders
-182.40
-1012.36%
19.99
+191.50%
6.86
-80.17%
34.58
Diluted EPS
—
0.18
+200.00%
0.06
-82.35%
0.34
Basic EPS
—
0.20
+185.71%
0.07
-79.41%
0.34
Basic Average Shares
—
102.40
-1.08%
103.51
+2.26%
101.23
Diluted Average Shares
—
109.42
+3.60%
105.62
+2.57%
102.98
Diluted NI Availto Com Stockholders
-182.40
-1012.36%
19.99
+191.50%
6.86
-80.17%
34.58
Depreciation Amortization Depletion Income Statement
15.66
-1.40%
15.88
-3.33%
16.43
+55.52%
10.57
Depreciation And Amortization In Income Statement
15.66
-1.40%
15.88
-3.33%
16.43
+55.52%
10.57
Earnings From Equity Interest
-0.55
-74.90%
-0.32
+7.95%
-0.34
-3949.49%
0.01
Gain On Sale Of PPE
-0.04
-267.50%
0.02
+102.78%
-0.85
-3926.56%
-0.02
Total Other Finance Cost
1.24
-35.61%
1.93
+214.53%
-1.68
-120.85%
-0.76
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
217.10
-52.35%
455.62
-7.10%
490.45
+24.71%
393.28
Current Assets
152.40
-49.95%
304.49
-10.15%
338.87
+25.01%
271.08
Cash Cash Equivalents And Short Term Investments
51.02
-42.83%
89.24
+50.53%
59.29
-62.32%
157.34
Cash And Cash Equivalents
51.02
-42.83%
89.24
+50.53%
59.29
-62.32%
157.34
Receivables
92.89
-55.95%
210.90
-19.53%
262.08
+154.46%
103.00
Accounts Receivable
92.89
-55.95%
210.90
-19.53%
262.08
+154.46%
103.00
Gross Accounts Receivable
101.19
-53.32%
216.77
-19.22%
268.36
+142.17%
110.81
Allowance For Doubtful Accounts Receivable
-8.30
-41.29%
-5.87
+6.41%
-6.28
+19.73%
-7.82
Prepaid Assets
4.79
+19.58%
4.01
—
—
Assets Held For Sale Current
—
—
0.00
-100.00%
4.48
Other Current Assets
3.70
+991.75%
0.34
-98.06%
17.50
+179.11%
6.27
Total Non Current Assets
64.70
-57.19%
151.13
-0.30%
151.58
+24.05%
122.20
Net PPE
43.50
+3.13%
42.18
+9.78%
38.42
-2.42%
39.37
Gross PPE
65.25
+8.93%
59.90
+17.22%
51.10
+6.70%
47.90
Accumulated Depreciation
-21.75
-22.70%
-17.73
-39.77%
-12.68
-48.79%
-8.52
Properties
0.00
0.00
0.00
0.00
Land And Improvements
0.04
+0.00%
0.04
+0.00%
0.04
+0.00%
0.04
Buildings And Improvements
0.53
+0.00%
0.53
+0.00%
0.53
+0.00%
0.53
Machinery Furniture Equipment
22.84
+5.76%
21.59
+2.15%
21.14
-9.89%
23.46
Other Properties
39.58
+8.42%
36.51
+27.25%
28.69
+23.17%
23.29
Leases
2.27
+82.90%
1.24
+74.61%
0.71
+22.42%
0.58
Goodwill And Other Intangible Assets
0.00
-100.00%
73.16
-14.15%
85.22
+37.75%
61.87
Goodwill
0.00
-100.00%
47.43
-0.23%
47.54
+22.21%
38.90
Other Intangible Assets
—
25.73
-31.72%
37.68
+64.06%
22.97
Investments And Advances
0.00
-100.00%
5.55
+902.21%
0.55
-7.43%
0.60
Long Term Equity Investment
0.00
-100.00%
5.55
+902.21%
0.55
-7.43%
0.60
Non Current Deferred Assets
0.54
-93.60%
8.42
-29.16%
11.89
+19.39%
9.96
Non Current Deferred Taxes Assets
0.54
-93.60%
8.42
-29.16%
11.89
+19.39%
9.96
Other Non Current Assets
20.67
-5.32%
21.83
+40.84%
15.50
+49.03%
10.40
Total Liabilities Net Minority Interest
91.23
-35.04%
140.44
-24.20%
185.28
+62.03%
114.35
Current Liabilities
67.49
-44.59%
121.81
-28.40%
170.12
+69.85%
100.16
Payables And Accrued Expenses
33.36
-42.93%
58.46
-40.93%
98.97
+38.21%
71.61
Payables
11.45
-59.67%
28.39
+2.66%
27.65
-42.19%
47.83
Accounts Payable
11.11
-60.82%
28.36
+43.02%
19.83
-8.13%
21.58
Other Payable
0.34
+1075.96%
0.03
-99.63%
7.82
-70.19%
26.24
Current Accrued Expenses
21.92
-27.14%
30.08
-57.83%
71.32
+199.89%
23.78
Pensionand Other Post Retirement Benefit Plans Current
20.87
+5.33%
19.82
+12.18%
17.67
+235.40%
5.27
Current Debt And Capital Lease Obligation
10.21
-73.51%
38.55
+23.03%
31.34
+447.57%
5.72
Current Debt
0.05
-99.83%
30.01
+19.92%
25.03
+3664.12%
0.66
Other Current Borrowings
0.05
+313.42%
0.01
-55.51%
0.03
-95.77%
0.66
Current Capital Lease Obligation
10.16
+18.99%
8.54
+35.39%
6.31
+24.70%
5.06
Other Current Liabilities
3.04
-38.86%
4.97
-77.54%
22.14
+26.11%
17.56
Total Non Current Liabilities Net Minority Interest
23.74
+27.40%
18.64
+22.91%
15.16
+6.84%
14.19
Long Term Debt And Capital Lease Obligation
18.97
+1.77%
18.64
+22.91%
15.16
+6.84%
14.19
Long Term Debt
0.18
+3425.27%
0.01
-87.46%
0.04
-96.64%
1.24
Long Term Capital Lease Obligation
18.78
+0.81%
18.63
+23.21%
15.12
+16.71%
12.96
Other Non Current Liabilities
4.78
—
—
—
Stockholders Equity
144.01
-55.12%
320.92
+6.69%
300.79
+10.09%
273.23
Common Stock Equity
144.01
-55.12%
320.92
+6.69%
300.79
+10.09%
273.23
Capital Stock
0.01
-3.21%
0.01
-2.07%
0.01
+1.61%
0.01
Common Stock
0.01
-3.21%
0.01
-2.07%
0.01
+1.61%
0.01
Share Issued
98.64
-3.21%
101.91
-2.06%
104.06
+1.61%
102.41
Ordinary Shares Number
98.64
-3.21%
101.91
-2.06%
104.06
+1.61%
102.41
Additional Paid In Capital
325.42
+1.35%
321.09
+0.12%
320.69
+6.38%
301.45
Retained Earnings
-183.80
-13008.41%
-1.40
+93.45%
-21.39
+26.16%
-28.97
Gains Losses Not Affecting Retained Earnings
2.39
+95.39%
1.22
-17.71%
1.48
+100.34%
0.74
Minority Interest
-18.14
-216.13%
-5.74
-231.13%
4.38
-23.18%
5.70
Other Equity Adjustments
2.39
+95.39%
1.22
-17.71%
1.48
+100.34%
0.74
Total Equity Gross Minority Interest
125.87
-60.06%
315.18
+3.28%
305.17
+9.41%
278.93
Total Capitalization
144.20
-55.07%
320.92
+6.68%
300.84
+9.61%
274.47
Working Capital
84.91
-53.52%
182.68
+8.25%
168.75
-1.27%
170.92
Invested Capital
144.25
-58.90%
350.94
+7.69%
325.86
+18.44%
275.13
Total Debt
29.18
-48.98%
57.19
+22.99%
46.50
+133.49%
19.91
Capital Lease Obligations
28.94
+6.53%
27.17
+26.80%
21.43
+18.96%
18.01
Net Tangible Assets
144.01
-41.87%
247.76
+14.93%
215.57
+1.99%
211.36
Tangible Book Value
144.01
-41.87%
247.76
+14.93%
215.57
+1.99%
211.36
Derivative Product Liabilities
—
—
—
0.00
Line Of Credit
0.00
-100.00%
30.00
+20.00%
25.00
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
34.45
-50.86%
70.12
+208.72%
-64.49
-323.39%
28.87
Cash Flow From Continuing Operating Activities
34.45
-50.86%
70.12
+208.72%
-64.49
-323.39%
28.87
Net Income From Continuing Operations
-196.37
-1569.75%
13.36
+32.96%
10.05
-67.32%
30.74
Depreciation Amortization Depletion
15.66
-1.40%
15.88
-3.33%
16.43
+55.52%
10.57
Depreciation
10.08
-1.42%
10.22
-8.57%
11.18
+52.13%
7.35
Amortization Cash Flow
5.58
-1.38%
5.66
+7.84%
5.25
+63.29%
3.21
Depreciation And Amortization
15.66
-1.40%
15.88
-3.33%
16.43
+55.52%
10.57
Amortization Of Intangibles
5.58
-1.38%
5.66
+7.84%
5.25
+63.29%
3.21
Other Non Cash Items
1.79
+119.11%
-9.36
-551.50%
-1.44
+51.82%
-2.98
Stock Based Compensation
17.44
+27.93%
13.63
-34.98%
20.97
+160.34%
8.05
Asset Impairment Charge
105.92
+682.18%
13.54
+276.01%
3.60
-46.54%
6.74
Deferred Tax
7.75
+123.43%
3.47
+274.94%
-1.98
+80.10%
-9.96
Deferred Income Tax
7.75
+123.43%
3.47
+274.94%
-1.98
+80.10%
-9.96
Operating Gains Losses
0.59
+102.64%
0.29
-76.91%
1.27
+213.54%
-1.12
Gain Loss On Investment Securities
—
—
—
-1.13
Gain Loss On Sale Of PPE
0.04
+267.50%
-0.02
-102.78%
0.85
+3926.56%
0.02
Change In Working Capital
81.66
+323.25%
19.29
+117.02%
-113.39
-760.62%
-13.18
Change In Receivables
112.50
+172.57%
41.27
+125.71%
-160.52
-1807.42%
-8.42
Changes In Account Receivables
112.50
+172.57%
41.27
+125.71%
-160.52
-1807.42%
-8.42
Change In Prepaid Assets
-3.40
-126.14%
13.01
+219.95%
-10.84
-159.36%
-4.18
Change In Payables And Accrued Expense
-28.04
+16.62%
-33.63
-159.09%
56.92
+2546.20%
-2.33
Change In Accrued Expense
-10.40
+75.20%
-41.94
-171.12%
58.97
+1088.74%
-5.96
Change In Payable
-17.64
-312.35%
8.31
+504.91%
-2.05
-156.41%
3.64
Change In Account Payable
-17.64
-312.35%
8.31
+504.91%
-2.05
-156.41%
3.64
Change In Other Working Capital
0.20
+509.80%
0.03
—
—
Change In Other Current Assets
0.41
+129.55%
-1.38
-230.69%
1.06
-39.38%
1.75
Investing Cash Flow
-39.08
-266.95%
-10.65
+64.03%
-29.61
+22.99%
-38.45
Cash Flow From Continuing Investing Activities
-39.08
-266.95%
-10.65
+64.03%
-29.61
+22.99%
-38.45
Net PPE Purchase And Sale
-4.34
-30.07%
-3.34
+49.16%
-6.57
-105.50%
-3.20
Purchase Of PPE
-4.54
-25.79%
-3.61
+50.60%
-7.31
-128.67%
-3.20
Sale Of PPE
0.20
-26.33%
0.27
-63.27%
0.75
+24802.93%
0.00
Capital Expenditure
-7.43
-32.42%
-5.61
+43.03%
-9.85
-79.25%
-5.50
Net Investment Purchase And Sale
13.16
+363.27%
-5.00
0.00
0.00
Purchase Of Investment
0.00
+100.00%
-5.00
0.00
0.00
Sale Of Investment
13.16
0.00
0.00
—
Net Business Purchase And Sale
-16.40
-5182.58%
-0.31
+98.49%
-20.50
+37.78%
-32.95
Purchase Of Business
-16.40
-5182.58%
-0.31
+98.49%
-20.50
+37.78%
-32.95
Gain Loss On Sale Of Business
0.00
0.00
-100.00%
0.07
0.00
Net Intangibles Purchase And Sale
-2.89
-44.38%
-2.00
+21.23%
-2.54
-10.53%
-2.30
Purchase Of Intangibles
-2.89
-44.38%
-2.00
+21.23%
-2.54
-10.53%
-2.30
Net Other Investing Changes
-28.61
—
—
—
Financing Cash Flow
-50.82
-110.38%
-24.15
-2259.21%
1.12
+118.10%
-6.18
Cash Flow From Continuing Financing Activities
-50.82
-110.38%
-24.15
-2259.21%
1.12
+118.10%
-6.18
Net Issuance Payments Of Debt
-35.17
-5831.91%
0.61
-97.04%
20.70
+625.92%
-3.94
Issuance Of Debt
0.26
-99.43%
45.00
+80.00%
25.00
0.00
Repayment Of Debt
-35.43
+20.19%
-44.39
-933.09%
-4.30
-9.14%
-3.94
Long Term Debt Issuance
0.26
-99.43%
45.00
+80.00%
25.00
0.00
Long Term Debt Payments
-35.43
+20.19%
-44.39
-933.09%
-4.30
-9.14%
-3.94
Net Long Term Debt Issuance
-35.17
-5831.91%
0.61
-97.04%
20.70
+625.92%
-3.94
Short Term Debt Issuance
—
—
25.00
0.00
Short Term Debt Payments
—
—
0.00
+100.00%
-0.03
Net Short Term Debt Issuance
—
—
25.00
+96695.96%
-0.03
Net Common Stock Issuance
-10.83
+21.28%
-13.76
0.00
+100.00%
-3.73
Common Stock Payments
-10.83
+21.28%
-13.76
0.00
+100.00%
-3.73
Repurchase Of Capital Stock
-10.83
+21.28%
-13.76
0.00
+100.00%
-3.73
Proceeds From Stock Option Exercised
0.00
-100.00%
0.03
-98.33%
1.58
-20.17%
1.98
Net Other Financing Charges
-4.82
+56.33%
-11.04
+47.85%
-21.17
-4201.24%
-0.49
Changes In Cash
-55.45
-257.03%
35.31
+137.97%
-92.98
-490.08%
-15.76
Effect Of Exchange Rate Changes
0.60
+412.53%
-0.19
-117.43%
1.09
+43.67%
0.76
Beginning Cash Position
107.34
+48.63%
72.22
-55.99%
164.11
-8.37%
179.11
End Cash Position
52.48
-51.10%
107.34
+48.63%
72.22
-55.99%
164.11
Free Cash Flow
27.02
-58.11%
64.50
+186.76%
-74.35
-418.11%
23.37
Interest Paid Supplemental Data
2.67
-8.26%
2.91
+242.37%
0.85
+12.39%
0.76
Income Tax Paid Supplemental Data
—
7.25
+70.51%
4.25
+182.46%
1.51
Common Stock Issuance
—
—
0.00
0.00
Earnings Losses From Equity Investments
0.55
+74.90%
0.32
-7.95%
0.34
+3949.49%
-0.01
Issuance Of Capital Stock
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category